[go: up one dir, main page]

AU2003282375A1 - Pharmaceutical compositions and process of production thereof - Google Patents

Pharmaceutical compositions and process of production thereof

Info

Publication number
AU2003282375A1
AU2003282375A1 AU2003282375A AU2003282375A AU2003282375A1 AU 2003282375 A1 AU2003282375 A1 AU 2003282375A1 AU 2003282375 A AU2003282375 A AU 2003282375A AU 2003282375 A AU2003282375 A AU 2003282375A AU 2003282375 A1 AU2003282375 A1 AU 2003282375A1
Authority
AU
Australia
Prior art keywords
production
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003282375A
Inventor
Yatish Kumar Bansal
Subhrangshu Sengupta
Nivedita Singh
Ramachandran Thembalath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipca Laboratories Ltd
Original Assignee
Ipca Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipca Laboratories Ltd filed Critical Ipca Laboratories Ltd
Publication of AU2003282375A1 publication Critical patent/AU2003282375A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003282375A 2003-02-05 2003-09-17 Pharmaceutical compositions and process of production thereof Abandoned AU2003282375A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN151MU2003 2003-02-05
IN151/MUM/2003 2003-02-05
PCT/IN2003/000312 WO2004069234A1 (en) 2003-02-05 2003-09-17 Pharmaceutical compositions and process of production thereof

Publications (1)

Publication Number Publication Date
AU2003282375A1 true AU2003282375A1 (en) 2004-08-30

Family

ID=32843822

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003282375A Abandoned AU2003282375A1 (en) 2003-02-05 2003-09-17 Pharmaceutical compositions and process of production thereof

Country Status (4)

Country Link
EP (1) EP1589957A1 (en)
AU (1) AU2003282375A1 (en)
NO (1) NO20042890L (en)
WO (1) WO2004069234A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070092573A1 (en) * 2005-10-24 2007-04-26 Laxminarayan Joshi Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist
PL204780B1 (en) * 2006-06-02 2010-02-26 Zak & Lstrok Ady Farmaceutyczn Coated tablet containing carbomer for extended release of indapamid, which release profile is adjusted exactly during the coating process
ATE533475T1 (en) * 2009-04-03 2011-12-15 Zaklady Farmaceutyczne Polpharma Sa EXTENDED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING METOPROLOL SUCCINATE
CN102008456B (en) * 2009-09-04 2015-01-14 鲁南制药集团股份有限公司 Novel skeleton sustained release tablet containing metoprolol succinate
IL210279A0 (en) 2009-12-25 2011-03-31 Dexcel Pharma Technologies Ltd Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients
CN102085195A (en) * 2011-01-10 2011-06-08 中国药科大学 Metoprolol succinate sustained-release tablets and preparation method thereof
SI3265126T1 (en) 2015-03-03 2021-11-30 Saniona A/S Tesofensine and metoprolol combination formulation
CA3062158A1 (en) * 2017-05-02 2018-11-08 Lubrizol Advanced Materials, Inc. Improved extended release highly loaded drug compositions
MX2021008208A (en) 2019-01-07 2021-11-17 Saniona As Tesofensine for reduction of body weight in prader-willi patients.
JP7784144B2 (en) 2020-04-22 2025-12-11 サニオナ エー/エス Treatment of hypothalamic obesity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE457505B (en) * 1984-01-10 1989-01-09 Lejus Medical Ab LAMINATED ORAL PHARMACEUTICAL COMPOSITION AND PROCEDURES FOR ITS PREPARATION
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
US5019302A (en) * 1986-03-12 1991-05-28 Washington University Technology Associates, Inc. Method for granulation
SE0100200D0 (en) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating

Also Published As

Publication number Publication date
EP1589957A1 (en) 2005-11-02
WO2004069234A1 (en) 2004-08-19
NO20042890L (en) 2004-07-07

Similar Documents

Publication Publication Date Title
AU2003202259A1 (en) Lipid compositions, production thereof and of esters
GB0321607D0 (en) Manufacture of pharmaceutical compositions
PL380851A1 (en) New piridine derivatives, way of their production and pharmaceutical compositions containing them
AU2003280458A1 (en) ss TITANIUM COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF
AU2003206803A1 (en) Production of alkenones
AU2003282375A1 (en) Pharmaceutical compositions and process of production thereof
AU2002361132A1 (en) Plasticine composition and process for production thereof
AU2003286944A1 (en) Crude drug compositions and the process for preparing them
WO2004089526A8 (en) Methods of providing product consistency
AU2003294684A1 (en) Ketoprofen compositions and methods of making them
AU2003251303A1 (en) Pharmaceutical products and methods of manufacture
AU2003279392A1 (en) Pharmaceutical compositions of azithromycin
AU2003261766A1 (en) Process for production of 4-alkylphenols
AU2003300018A1 (en) Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents
AU2003295713A1 (en) Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
EP1694242A4 (en) Pharmaceutical formulations of camptothecins and process for making same
AU2003282377A1 (en) Dual release anti-diabetic drugs and process of production thereof
AU2003292820A1 (en) 4-amino-5-methylpyrazole derivatives and process for production thereof
AU2003273006A1 (en) Process for production of fluoropolymers and photoresist composition
AU2003290647A1 (en) Pharmaceutical compositions and methods of using taxane derivatives
AU2002239018A1 (en) Production of ugppase
AU2003260518A1 (en) Polymorphic forms of dorzolamide chlorhydrate, production method thereof and pharmaceutical compositions containing same
AU2003235129A1 (en) Process for preparation of 2-aminoketones
AU2003210220A1 (en) Production of epi-hne-4 comprising reduction of improperly processed form
AU2003285530A1 (en) Production of biocompounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase